Allogene Therapeutics, Inc.
← Back to ALLO Overview

Allogene Therapeutics, Inc. (ALLO)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.95

Financial Fundamentals

ALLOQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-12-31-137535.23
2018-03-31-105.92
2018-06-30-5.27
2018-09-30-16.34
2018-12-31-18.11
2019-03-31-22.13
2019-06-30-17.15
2019-09-30-13.73
2019-12-31-11.15
2020-03-31-9.72
2020-06-30-20.26
2020-09-30-18.11
2020-12-31-11.95
2021-03-31-35.33
2021-06-30-12.39
2021-09-30-11.26
2021-12-31-6.93
2022-03-31-4.03
2022-06-30-5.46
2022-09-30-4.67
2022-12-31-2.39
2023-03-31-1.79
2023-06-30-2.30
2023-09-30-2.13
2023-12-31-1.51
2024-03-31-2.85
2024-06-30-1.67
2024-09-30-2.21
2024-12-31-1.87
2025-03-31-1.32
2025-06-30-1.21
2025-09-30-1.66
2025-12-31-1.95

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.